Valuation: Healius Limited

Market Cap 290M 202M 180M 168M 153M 288M 19.56B 2.02B 790M 9.94B 758M 742M 31.97B P/E 2027 *
-29.3x
P/E 2028 * 74.8x
Enterprise Value 1.17B 815M 727M 679M 616M 1.16B 78.9B 8.15B 3.19B 40.09B 3.06B 2.99B 129B EV / Sales 2027 *
0.84x
EV / Sales 2028 * 0.82x
Free-Float
77.73%
Yield 2027 *
-
Yield 2028 * 1.47%
1 day-1.25%
1 week-5.95%
Current month-8.14%
1 month-15.05%
3 months+2.60%
6 months-24.76%
Current year-56.35%
1 week 0.39
Extreme 0.3925
0.42
1 month 0.36
Extreme 0.36
0.46
Current year 0.3
Extreme 0.3
1.05
1 year 0.3
Extreme 0.3
1.07
3 years 0.3
Extreme 0.3
2.3
5 years 0.3
Extreme 0.3
5.54
10 years 0.3
Extreme 0.3
5.54
Manager TitleAgeSince
Chief Executive Officer - 2024-03-04
Director of Finance/CFO - 2025-10-12
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member - 2018-08-20
Chairman 65 2023-11-27
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap. Importance
8/27/26 Expiration

Director

-22,977 0.0032%
8/27/26 Exercice

Director

22,977 0.0032%
8/18/26 Expiration

Chief Executive Officer

-305,462 0.0421%
Change 5-day change 1-year change 3-year change Capi.($)
-1.25%-5.95%-50.62%-82.05% 207M
-0.17%+3.05%+14.13%+25.61% 112B
+1.33%+5.11%+4.40%+81.36% 95.08B
-1.21%-4.33%+127.08%+797.34% 57.02B
-0.21%-2.18%-5.47%+55.95% 27.29B
+0.71%+3.15%+13.22%+56.02% 25.3B
+1.65%-0.12%+27.60%+85.73% 25.06B
+0.26%+0.97%-15.92%-3.09% 21.27B
+0.28%+2.60%+29.97%+322.59% 20.92B
+2.61%+18.47%+11.12%+85.92% 19.35B
Average +0.40%+1.14%+15.55%+142.54% 40.4B
Weighted average by Cap. +0.38%+1.47%+26.30%+172.04%

Financials

2027 *2028 *
Net sales 1.4B 973M 869M 811M 737M 1.39B 94.28B 9.74B 3.81B 47.91B 3.66B 3.58B 154B 1.44B 1B 893M 833M 757M 1.42B 96.88B 10B 3.91B 49.23B 3.76B 3.67B 158B
Net income -11.5M -8M -7.14M -6.66M -6.05M -11.39M -774M -79.98M -31.28M -394M -30.02M -29.37M -1.27B 648K 450K 402K 375K 341K 641K 43.62M 4.5M 1.76M 22.17M 1.69M 1.65M 71.29M
Net Debt 881M 613M 547M 510M 464M 872M 59.33B 6.13B 2.4B 30.15B 2.3B 2.25B 96.96B 885M 615M 550M 513M 466M 876M 59.61B 6.16B 2.41B 30.29B 2.31B 2.26B 97.41B
Projected Income Statement - Annual - Healius Limited
Logo Healius Limited
Healius Limited is a healthcare company. The Company's specialized pathology businesses deliver healthcare services across Australia. It provides pathology services, including specialty pathology and clinical trials. It offers medical laboratory and pathology services through a variety of specialty brands. It provides medical laboratory and pathology services across key diagnostic activities. These include anatomical pathology (histopathology and cytology), clinical pathology (biochemistry, hematology, immunology and microbiology), genomic diagnostics and veterinary pathology. Its brands include Abbot, Agilex Biolabs, Dorevitch, Gastrolab, Genomic Diagnostics, IQ Pathology, Kossard Dermatopathology, Laverty Pathology, QML Pathology, TML Pathology, Vetnostics Pathology and Western Diagnostic Pathology (WDP). These brands operate in Queensland, New South Wales (including the Australian Capital Territory), Victoria, Western Australia and Northern Territory, Tasmania, and South Australia.
Employees
5,419
Date Price Change Volume
26-10-08 A$0.3950 -1.25% 99,948
26-10-08 A$0.4000 -2.44% 1,227,178
26-10-07 A$0.4100 0.00% 2,719,041
26-10-06 A$0.4100 +1.23% 4,501,124
26-10-05 A$0.4050 +2.53% 1,346,073
Trader
Investor
Global
Quality
ESG MSCI
AA
Ratings Surperformance© - Healius Limited
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
10
Last Close Price
0.4000AUD
Average target price
0.5494AUD
Spread / Average Target
+37.35%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Healius Limited